Retrospective analysis of the drug-coated balloon-only strategy for chronic total occlusion coronary lesions.

ABSTRACT:

Background

The effects of the drug-coated balloon (DCB)-only strategy in the treatment of chronic total occlusion (CTO) coronary lesions remain controversial. Patients who underwent an in-stent restenosis (ISR) CTO percutaneous coronary intervention (PCI) had a significantly poorer prognosis than those who underwent a de novo CTO PCI. This retrospective analysis evaluated the efficacy and safety of the DCB-only strategy in the treatment of CTO lesions, and the factors associated with adverse events in the patients.

Methods

Patients with CTO lesions who were treated with the DCB-only strategy from 1 January 2016 to 1 May 2021 were retrospectively enrolled in this study. The patients were stratified into the ISR and de novo (primary) groups. All the patients were

SUBMITTER: Li P 

PROVIDER: S-EPMC11388238 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature